Journal Cluster Webinar | Cognitive Impairment After Stroke: Current Research Into Neuropathology, Evaluation and Management
Journal Cluster Webinar | Cognitive Impairment After Stroke: Current Research Into Neuropathology, Evaluation and Management
Part of the MDPI Journal Cluster Webinar series
26 September 2025
Cognition, Stroke, Vascular Cognitive Impairment, Vascular Dementia, Cognitive Assessment, Neuropathology, Imaging Markers, Spatial Neglect, Quality of Life
Welcome from the Chairs
MDPI's Journal Cluster of Neurosciences
Cognitive Impairment After Stroke: Current Research Into Neuropathology, Evaluation and Management
Thank you so much for joining today’s webinar on post-stroke cognitive impairment. We believe this is a topic of great importance and interest.
Evaluating cognitive impairment following stroke and finding ways to alleviate it have been identified as top research priorities by both healthcare professionals and, most importantly, those affected by stroke.
Post-stroke cognitive deficits in one or multiple domains - such as attention, memory or language - are common. Some reports even suggest that two out of three stroke survivors may experience them at some point. Stroke also more than doubles the risk of developing dementia - the most severe form of cognitive impairment. And this cognitive aftermath of stroke can then severely compromise independence, social participation, and overall quality of life.
This is why, today, we’re excited to showcase research from around the world that aims to deepen our understanding of the mechanisms and impact of post-stroke cognitive impairment, and explore how best to assess, predict, prevent, and manage cognitive dysfunction.
We have six excellent talks lined up.
Date: 26 September 2025
Time: 5pm CEST | 11am EDT
Webinar ID: 898 3851 9309
Webinar Secretariat: journal.webinar@mdpi.com
Registration
This is a FREE webinar. After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Certificates of attendance will be delivered to those who attend the live webinar.
Can’t attend? Register anyway and we’ll let you know when the recording is available to watch.
Event Chairs
Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
Website
Bogna holds master’s degrees in Psychology and Brain Injury Rehabilitation, with her training and career focused on clinical research in cerebrovascular disease. She completed her PhD in 2021 at the University of Glasgow, where her research investigated the prognosis of cognitive impairment following stroke. Currently, she is a postdoctoral associate in the Department of Clinical Neurosciences at the University of Calgary. Her work integrates both quantitative and qualitative methodologies, with a strong emphasis on patient-centred outcomes.
School of Health Sciences, Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, UK
Website
Short bio: Emma is a mixed methods researcher with a background in psychology. She has worked in clinical research since 2014, with roles in the NHS, university, and consultancy. Emma completed her PhD at the University of Glasgow which examined measurement properties and diagnostic accuracy of cognitive screening instruments. Prior to joining the University of Manchester, Emma was working as a Senior Research Scientist at Modus Outcomes, a patient centred outcomes research consultancy.
Invited Speakers
Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia
Memory Lucy Mtambo is a PhD candidate at the Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia. She researches post-stroke cognitive impairment in community-dwelling survivors and aims to provide evidence to strengthen prevention and health promotion strategies in rural and remote areas of low- and middle-income countries.
Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
Thomas is entering the second year of his MSc in Biomedical Engineering at the University of Calgary, studying under Dr. Philip A. Barber and Dr. M. Ethan MacDonald. His research looks to combine multimodal biomarkers, including MR imaging, blood tests, genotyping, and demographic data, with machine learning to predict late life cognitive decline in stroke patients. Before his master’s, Thomas was a chemical engineer, working in the energy industry for over three years.
Department of Neurology, McGovern Medical School, University of Texas Health Science Center, Houston, United States
Dr. Ritzel conducted his graduate studies on stroke immunology in the Department of Neuroscience at the University of Connecticut Health Center and obtained his PhD in 2016. He then pursued postdoctoral training at the Shock, Trauma and Anesthesiology Research Center at the University of Maryland School of Medicine in Baltimore, where he studied neuroimmune interactions in chronic traumatic brain injury. Dr. Ritzel received the inaugural Michael Shipley Postdoctoral Award for excellence in neuroscience research and has been the recipient of NINDS F31, F32, and K99/R00 training awards. His translational neuroscience laboratory at the University of Texas Health Science Center in Houston is actively investigating the neuroimmune interactions underlying CNS aging, acute brain injury, and chronic neurodegeneration.
Department of Neuropsychology, National Hospital for Neurology and Neurosurgery, University College London Hospitals, London, United Kingdom
Dr. Edgar Chan is a Consultant Clinical Neuropsychologist. He completed his undergraduate degree in Psychology at the University of Melbourne and his post-graduate professional training in Clinical Psychology and Clinical Neuropsychology at the University of Queensland. He obtained a PhD in Cognitive Neuroscience at the Queensland Brain Institute and has been working in the Department of Neuropsychology at the National Hospital for Neurology and Neurosurgery Queen Square since 2013. He is also an Honorary Senior Research Associate with the Stroke Research Group at the Institute of Neurology, UCL.
School of Psychology, University of East Anglia, Norwich, United Kingdom
Dr. Yidian Gao is a postdoctoral researcher with a clinical neuroscience and psychiatry background. Having completed her doctoral and master’s studies at Second Xiangya Hospital, China, Yidian’s primary research interest lies in utilizing multi-site neuroimaging data to generate more robust, generalizable insights for clinical neuroscience challenges, such as conduct disorder and mild traumatic brain injury. In her recent work, she has led and contributed to international collaborations (including ENIGMA-Antisocial Behavior and mTBI-PREDICT), focusing on data harmonization and open-science practices. Ultimately, Yidian aims to translate these large-scale, multi-modal findings into meaningful clinical applications that can enhance patient outcomes and inform future interventions.
Program
| Speaker/Presentation | Time in CEST | Time in EDT |
|
Bogna Anna Drozdowska & Emma Elliott (Chair) Chair Introduction |
5:00 - 5:10 pm | 11:00 - 11:10 am |
|
Memory Lucy Mtambo (Speaker 1) The Impact of Stroke on Cognitive Function and Quality of Life among Community Survivors |
5:10 - 5:20 pm | 11:10 - 11:20 am |
| Q&A for Memory Lucy | 5:20 - 5:25 pm | 11:20 - 11:25 am |
|
Thomas Oldreive (Speaker 3) MRI Biomarkers of Cognition in Transient Ischemic Attack |
5:25 - 5:35 pm | 11:25 - 11:35 am |
| Q&A for Thomas Oldreive |
5:35 – 5:40 pm |
11:35 - 11:40 am |
|
Dr. Rodney Ritzel (Speaker 4) Neuropathological Hallmarks during the Chronic Phase of Ischemic Stroke in Mice and Humans |
5:40 - 6:00 pm |
11:40 am - 12:00 pm |
| Q&A for Rodney Ritzel |
6:00 – 6:05 pm |
12:00 - 12:05 pm |
|
Dr. Edgar Chan (Speaker 5) Queen Square Cognitive Screen (Q-CAS) – Validation in Stroke |
6:05 - 6:15 pm |
12:05 - 12:15 pm |
|
Q&A for Edgar Chan |
6:15 - 6:20 pm |
12:15 - 12:20 pm |
|
Dr. Yidian Gao (Speaker 6) Spatial Inattention Grasping Therapy (SIGHT) for Rehabilitation of Spatial Neglect Post-Stroke: A Randomised-Controlled Multicentre Efficacy Trial with Embedded Mechanistic Study of Determinants of Therapy Response |
6:20 - 6:40 pm |
12:20 - 12:40 pm |
|
Q&A for Yidian |
6:40 – 6:45 pm |
12:40 - 12:45 pm |
|
Bogna Anna Drozdowska & Emma Elliott (Chair) Closing of Webinar |
6:45 – 6:50 pm |
12:45 - 12:50 pm |
Sponsors and Partners
Organizers
